ReNeuron Group Company

Stroke oriented, stem cell therapies. Primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
Technology: AgeTech Companies
Industry: Healthcare
Headquarters: United Kingdom
Founded Date: 01.01.1997
Employees Number: 51-100
Funding Status: IPO
Acquisitions Number: 1
Investors Number: 4
Total Funding: 167 333 065
Estimated Revenue: $1M to $10M
Last Funding Date: 10.07.2015
Last Funding Type: Post-IPO Equity

Visit Website
info@reneuron.com
https://www.twitter.com/todd55marsh
Register and Claim Ownership